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Can experiments in nonhuman primates 
expedite the translation of treatments for 
spinal cord injury in humans?
Grégoire Courtine1, Mary Bartlett Bunge2, James W Fawcett3, Robert G Grossman4, Jon H Kaas5, Roger Lemon6, 
Irin Maier7, John Martin8, Randolph J Nudo9, Almudena Ramon-Cueto10, Eric M Rouiller11, Lisa Schnell9,  
Thierry Wannier11, Martin E Schwab9 & V Reggie Edgerton1
Progress continues in the development of 
reparative interventions to enhance recovery 
after experimental spinal cord injury (SCI). 
Here we discuss to what extent rodent models 
of SCI have limitations for ensuring the efficacy 
and safety of treatments for humans, and under 
what circumstances it would be advantageous 
or necessary to test treatments in nonhuman 
primates before clinical trials. We discuss 
crucial differences in the organization of the 
motor systems and behaviors among rodents, 
nonhuman primates and humans, and argue 
that studies in nonhuman primates are critical 
for the translation of some potential interven-
tions to treat SCI in humans.
Traumatic SCI has long-term health, eco-
nomic and social consequences worldwide1,2, 
giving a sense of the urgency to the develop-
ment of ways to treat it. Treatments that lead 
to at least partial functional recovery after SCI 
can substantially improve the quality of life 
of affected individuals. Consequently, there is 
considerable need to take to the clinic those 
interventions that have shown effectiveness in 
promoting functional improvement in labora-
tory animals.
Progress continues in the identification of 
interventions that augment plasticity after 
injury by promoting axonal regeneration and 
sprouting in rodents3–6. Some of these treat-
ments may be efficacious in patients with SCI, 
and have or are entering phase 1 clinical trials. 
Important differences exist, however, between 
the nervous systems of rodents and humans, 
in terms of size, neuroanatomical, neurophysi-
ological and behavioral characteristics, and 
inflammatory and immunological responses. 
Here we point out limitations of the commonly 
used rodent models in ensuring the efficacy 
and safety of SCI treatments for humans, and 
discuss how the use of nonhuman primates can 
facilitate the successful advancement of poten-
tial treatments to clinical trials.
We primarily focus on motor performance, 
as this behavior is well studied and there are 
important similarities between some non-
human primates and humans in the orga-
nization of the neural systems that control 
movement. However, a similar examination of 
autonomic and other neural functions compro-
mised after SCI would also be useful for a more 
comprehensive strategic approach in optimiz-
ing functional recovery after SCI (Box 1). 
We conclude that studies in nonhuman pri-
mates can probe the effects of therapy-induced 
neural plasticity on multiple aspects of func-
tional recovery with a refinement that cannot 
be attained in rodents.
Important differences between rodents 
and primates
Neuroanatomy. Although there is remark-
able conservation among the motor systems 
of vertebrates, some features have undergone 
pronounced evolutionary changes7,8. This is 
particularly true of the motor cortex and its 
descending output—the corticospinal tract 
(CST)—which projects extensively to the 
brainstem and spinal cord in primates. In many 
primates, the CST can influence motoneuron 
activity both directly and indirectly8. Indeed, 
over the course of the evolution of human and 
nonhuman primates there has been a massive 
increase in the proportion and actual size of the 
neocortex that gives rise to the CST, a fast-con-
ducting component of the CST has appeared, 
and the corticospinal axons have changed loca-
tion from the dorsal to the lateral columns of 
the spinal cord9.
Differences between rodents and primates in 
the pattern of CST terminations are qualitative 
and quantitative. In rodents, the CST projects 
mainly to dorsal horn neurons and premotor 
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spinal circuits. In many nonhuman primates, 
such as the rhesus monkey, the projection 
pattern of the CST is much more complex: a 
significant proportion of CST fibers projects 
to the ventral horn, and some axons synapse 
directly on motoneurons8, in particular those 
innervating hand muscles. In humans, this 
trend is even more marked10. Stimulation of 
CST neurons in the motor cortex evokes motor 
responses that markedly differ in primates 
compared to rodents11, as well as between dif-
ferent primate species8. For example, there is 
a strong correlation between the number of 
direct connections between cortex and motor 
neurons and the level of manual dexterity of 
nonhuman primate species (ref. 8 and Fig. 1).
There also are substantial differences between 
rodent and most primates in the distances over 
which neural fibers might be required to regen-
erate after injury. This difference could limit 
the inferences that can be made from regen-
eration studies between rodents and primates. 
This is relevant for injury to the cervical spinal 
cord, but may be even more problematic for 
reinnervation of the lumbar regions, owing to 
the long distance that fibers may need to travel 
to reach locomotor circuits in humans.
Behavior.  The development of the descend-
ing motor pathways has enabled primates to 
perform incrementally recruit portions of the 
motoneuron pools that innervate distal mus-
cles, and has contributed to an increased ability 
to control hand musculature11–13. In particular, 
there is evidence that the appearance of direct 
cortical projections to spinal motoneurons 
correlates with the emergence of precision 
grip between the thumb and the index fingers, 
which exists in only some primates (ref. 8 and 
Fig. 1). Accordingly, and unlike in rodents13–15, 
interruption of the cortical projections to the 
spinal cord in primates causes a major impair-
ment in fine motor function of the hands and 
feet, the magnitude of which is most severe in 
humans (ref. 16 and Table 1).
Likewise, CST lesions have little effect on 
stepping in rodents17, indicating that the 
motor cortex is not essential for creating the 
muscle synergies that sustain simple locomo-
tion in rats and mice. By contrast, damage 
to the CST in rhesus monkeys provokes per-
manent deficits during stepping15,18, and in 
humans, CST damage leads to a motor impair-
ment severe enough to compromise indepen-
dent walking16.
So, even though fine motor control of the 
forelimb can be tested in rodents and is affected 
by lesions to the CST (ref. 19), the finesse in 
digital control is far less developed in rodents 
than in nonhuman primates, and there are 
marked differences in the musculoskeletal 
design of the forelimb, hand and distal digit 
musculature between primates and rodents. 
Although it has not been directly explored, 
Figure 1  Relationship between the development of the corticospinal tract and the emergence of fine motor control abilities. In rodents, there are no direct 
connections between corticospinal neurons and the cervical motoneurons that innervate forelimb muscles—interneurons relay cortical input to motor 
neurons. In the evolution of the corticospinal tract in nonhuman primates and humans, direct corticospinal connections with motoneurons have emerged, 
together with an increase in the size and number of the corticospinal fibers. Accordingly, the size of the excitatory postsynaptic potential (EPSP) elicited by 
cortical neurons on motoneurons has increased during primate evolution. Furthermore, most of the corticospinal tract fibers in rodents travel in the dorsal 
columns. In contrast, the primate corticospinal tract is mostly located in the lateral columns, and a significant proportion of corticospinal fibers (10–20%) 
descend ipsilaterally. Development of the corticospinal tract correlates with the improvement in the index of dexterity (as quantified in ref. 30), particularly in 
the ability to perform finger-thumb precision grip. Figure adapted from ref. 31.
Box 1  There are critical differences in other neurological systems of 
rodents, nonhuman primates and humans
Although our focus is on neuromotor function and the safety of interventions designed 
to improve function after SCI, other functional aspects should be similarly examined 
with respect to the potential advantages of using nonhuman primates instead of rodents. 
For example, methods to improve recovery of autonomic functions are ranked as very 
important by SCI patients1. The overall architecture of the autonomic neural pathways 
is similar among mammals, but bladder control and sexual function are more similar 
between humans and nonhuman primates than between humans and rodents. Issues of 
autonomic control, such as blood pressure changes when assuming a vertical posture 
after a SCI, are also important, and nonhuman primate experiments are likely to provide a 
better predictor of the effects of a given treatment on humans than findings from rodents.
Rodents
(rats)
Manual
dexterity
Amplitude of corticomotoneural-EPSPs
2 mV
Number of fibers
per tract
Interneuron
Motoneuron
137,000 Not known 400,000 1,101,000
New world monkeys
(squirrel)
Old world monkeys
(macaque)
Humans
3 5 6 7
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testing in nonhuman primates might there-
fore provide a better prediction of the poten-
tial of therapies for SCI to mediate recovery of 
manual dexterity and stepping.
Detailed assessments of motor capacity can 
be comprehensive in nonhuman primate SCI 
studies. From the perspective of clinical trials, 
an advantage of testing motor performance in 
nonhuman primates is the similarity in func-
tional measures between them and humans, 
as compared to rats. Indeed, the precision 
grip, pre-shaping of the hand, grasping and 
other manual prehensile tasks performed by 
macaques and other Old World monkeys are 
very similar to these behaviors in humans. By 
contrast, testing fine motor control in rodents 
remains limited to a coarse success-rate 
assessment. In rare cases, time-consuming 
video analysis has been used, but the detailed 
fine control of the distal phalanges in rodents 
remains rudimentary19. Moreover, assessment 
of cortical connectivity, supraspinal access to 
spinal motoneurons and segmental circuit 
properties can be performed similarly in non-
human primates and humans.
Evaluation of motor behavior after SCI 
should include careful documentation of how 
different manual functions are performed 
over the course of the recovery period. In 
particular, combined analyses of motor pool 
recruitment patterns and kinematics of the 
head, trunk and limbs can provide decisive 
information on the degree to which the ani-
mal recovers using compensatory strategies 
to perform the task successfully. Transcranial 
magnetic stimulation, magnetic resonance 
imaging and measurement of sensory-evoked 
potentials can provide additional tools for 
obtaining very similar motor performance–
related data in nonhuman primates and 
humans.
It is also important to assess stepping ability 
and other key motor functions. The extent to 
which stepping and grasping differ in their 
underlying neural processes and the primate’s 
intrinsic capacity to recover these func-
tions after a SCI are not fully understood15. 
Engaging the neural circuits for stepping may 
facilitate the recovery of timing in the recruit-
ment of antagonistic motor pools after injury 
and promote restoration of fine motor control 
(G. Courtine et al., Soc. Neurosci. Abstr. 654.7, 
2004), and this capability may be unique to 
nonhuman primates.
In examining locomotor behavior, it is also 
possible to study bipedal walking in primates. 
In addition to quadrupedal locomotion, many 
primate species practice bipedal walking with 
characteristics close to human walking, and 
bipedal stepping on a treadmill or over ground 
can be tested and quantified20. Furthermore, 
manually or robotically assisted bipedal step 
training after SCI can be implemented in non-
human primates.
Beyond the CST. Differences in motor sys-
tems suggest that strategies to promote regen-
eration of the nervous system might influence 
rodents differently from primates, resulting 
in divergent anatomical and functional out-
comes. Even if there were similar outcomes, 
the neurological basis for the improvement 
may differ substantially, owing to these func-
tional differences. For example, compared to 
rodents, primates engage more complex neural 
circuits in the parietal and frontal lobes of the 
cerebral cortex even for the simplest of skilled 
movements.
This reliance of primates on the cortex for 
motor function may, in turn, offer greater 
plasticity and recovery after partial SCI. For 
example, sprouting of spared CST fibers to 
the descending motor systems and associated 
changes in the organization of the cortex may 
provide a unique capacity for plasticity, which 
can lead to improvement in motor function, 
particularly if fiber growth can be enhanced. 
Treatments that promote plasticity in rodents 
might be considerably more efficacious in non-
human primates and in humans. So, although 
technically challenging, there is a clear need to 
analyze changes in the cerebral cortex18,21–23 
as well as responses of non-CST descending 
pathways when testing a treatment in primates 
with SCI. The potential for reorganization at 
multiple sites in the brain after SCI may be an 
effective means to enhance motor recovery in 
response to incomplete injuries24.
Similarly, to what extent could regeneration 
of a few ascending fibers across the injury site 
restore sensory function and contribute to 
improved motor behavior? These possibilities 
could not be tested with the same resolution 
in rodents, as sensory discrimination does 
not seem to be as critical for manual dexter-
ity in rodents as it is in primates, nor is the 
response to injury of the sensory area in the 
brain similar25.
When should we choose nonhuman 
primates over rodents?
Rodent and feline models have been used for 
the development of the current treatments 
that are under consideration for use after a 
SCI, and they have to remain the mainstay of 
experimentation. However, testing some forms 
of treatments in nonhuman primates before 
undertaking human trials is likely to provide 
essential information on the efficacy as well 
as the possible adverse effects of specific treat-
ments. As implied above, a major advantage in 
using nonhuman primates is the technical capa-
bility to comprehensively examine a range of 
highly skilled motor functions of the hand 
using electrophysiological and biomechanical 
tools. Furthermore, it is feasible to monitor the 
degree to which, and how, different neuromus-
cular components contribute to the wide range 
of hand functions. There are, however, other 
factors that should inform our decision to use 
nonhuman primates to test therapies for SCI.
Efficacy and safety. The key factor in decid-
ing whether a potential intervention should 
be studied in nonhuman primates instead of 
rodents relates to efficacy and safety: to what 
extent can the efficacy and safety of a given 
treatment be assessed in rodent studies? There 
are many questions that can be addressed effec-
tively in the rodent that can improve the prob-
ability of successful extrapolation to humans.
In the context of cell-replacement therapy, 
for example, there are several questions for 
which studies in rodents can be very infor-
mative: which cell types and how many cells 
should be implanted, what percentage of cells 
survive after implantation, what the postopera-
tive procedures should be to maximize their 
effectiveness, how much of a specific growth 
factor should be administered, and what types 
of immunological, urological, respiratory, sen-
sory and motor effects might be expected to 
occur, and over what time frame.
In addition, studies in rodents can give us 
early warnings of the secondary effects of a 
given therapy. For example, aberrant axonal 
sprouting associated with allodynia-like hyper-
sensitivity of the forepaws has been reported 
after intraspinal graft of neural stem cells in a 
model of rodent SCI (ref. 26).
Although work in rodents has answered 
some of these primary questions, studies in 
nonhuman primates might be necessary to 
more accurately predict the optimal treat-
ment procedures to use in humans. In the 
same context of cell-replacement therapy, or 
when studying the administration of growth 
Table 1  Effect of interruption of corticospinal tract on locomotion and manual dexterity
Locomotion Manual dexterity
Rodents No significant disruption of the  locomotor function
Significant alteration followed by  
limited to extensive recovery 
Macaque monkeys Some permanent locomotor deficits Complete loss of function followed by  limited recovery
Humans Loss of independent walking capabilities Permanent deficits of function
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factors or agents that neutralize neurite 
growth inhibitors, experiments in nonhu-
man primates using the conditions outlined 
by experiments in rodents could help insure 
faster, safer and more efficacious use in 
humans with SCI (ref. 14).
Likewise, inflammatory and immune 
responses differ between primates and 
rodents7, and could contribute to altered sec-
ondary cell damage, removal of debris after 
trauma, neural plasticity and functional recov-
ery. These differences could render a neural 
intervention that is beneficial in rodents to 
be ineffective in primates. These factors sug-
gest that potential interventions can be tested 
stringently in nonhuman primates while pro-
viding quantitative assessment of efficacy. In 
effect, these results could critically enhance 
the safety of the patients participating in a 
clinical trial.
Ethical and financial considerations. There 
are continuing discussions regarding the 
instances in which nonhuman primates can 
be used in research. For example, in a recently 
published report27, the UK’s Medical Research 
Council and the Wellcome Trust concluded 
that, although there is a need to review the 
ethical and scientific justification for primate 
use and for strict legal controls, some biomedi-
cal problems are such that alternatives are not 
available or appropriate and it is important to 
conduct research on nonhuman primates. In 
the case of SCI, trying to optimize the condi-
tions for a given treatment in human studies 
would be limited by the number of patients 
available for trials and would be highly prob-
lematic from an ethical standpoint.
Admittedly, almost all studies on nonhuman 
primates are expensive and challenging, and 
there are only a limited number of laborato-
ries that have the necessary skills and resources 
to carry out experiments that can examine all 
the functions that are affected by the treatment 
being tested. But even though they are expen-
sive, cumbersome and technically more com-
plex than experiments in rodents, studies in 
nonhuman primates remain far less expensive 
than clinical trials in humans. Indeed, the finan-
cial cost associated with a single human clinical 
trial could support several primate studies that 
could lead to greater and more rapid advances 
in our development of treatments for SCI. The 
cost/benefit ratio of experiments in nonhuman 
primates was discussed within the framework 
of the current international standards for the 
use of experimental subjects. We recognize 
that experiments should be performed only if 
there is no other way of obtaining the results 
or if, as judged by the appropriate governing 
bodies, the benefits of the work outweigh the 
costs of the animals involved. On the basis of 
differences in the organization of sensorimo-
tor systems between rodents and primates, 
as well as the safety factors that we discussed 
above, we argue that the limited and optimized 
use of nonhuman primates, such as macaque 
monkeys (Box 2), can be highly beneficial in 
efforts to improve treatment efficacy and safety 
in humans after SCI.
Other practical considerations
SCI models can be categorized as contusion, 
anatomically incomplete transection and ana-
tomically complete transection. Each of these 
models has advantages and disadvantages that 
should be taken into account when design-
ing translational investigations in nonhuman 
primates (Table 2). In any case, it is essential 
that the lesion model induces a permanent and 
reproducible deficit in at least one area of sen-
sory, motor or autonomic function. Otherwise, 
the model cannot be used to test effective inter-
ventions.
Contusion. Because most human SCI results 
from blunt trauma, as opposed to partial or 
complete transection, contusion models are 
considered to resemble human SCI more 
closely than transection approaches. Contusion 
models can have predictable and consistent 
functional outcomes that allow testing of 
potential therapies, particularly those that 
mitigate the formation of lesion cavities and 
enhance tissue sparing.
Contusion injuries also provide a model 
with which to test the effect of transplanting 
cells or materials to fill the lesion site. However, 
ischemia, cavity formation and the partial tis-
sue sparing associated with such lesions add 
significantly to the complexity of dissecting 
the mechanisms associated with functional 
improvements after therapeutic manipulations. 
When the goal is to investigate specific neural 
mechanisms underlying therapy-mediated 
recovery or to distinguish between spared and 
regenerated nerve fibers, transection models 
are preferable. Last, the sometimes severe loss 
of function after contusion must be weighed 
against the potential benefits of using this type 
of lesion.
Incomplete transection. Several types of 
incomplete spinal cord transection are suit-
able for testing the effects of a treatment that 
promotes sprouting from spared axons and, 
perhaps, axon regeneration. This approach 
is also suitable for correlating axonal changes 
with specific behavioral improvements. An 
advantage of these models is that animals rap-
idly recover postural control to a large extent 
after incomplete lesions, thereby allowing bet-
ter assessment of arm and hand functions.
Another key advantage of incomplete lesions 
in studying motor functions is that critical 
physiological functions, such as bladder and 
bowel functions, are preserved. Also, less 
animal handling is needed because of partly 
spared postural and locomotor capabilities. 
Lastly, permanent, albeit modest, impairments 
in both fine motor control and locomotion 
readily allow the assessment of the potential 
of use-dependent mechanisms to enhance 
recovery24 (H. Yang et al., Soc. Neurosci. Abstr. 
106.14, 2004; Wannier, T. et al., Soc. Neurosci. 
Abstr. 103.2, 2005).
Surgically incomplete spinal cord transec-
tions provide an avenue for investigating the 
Box 2  Which nonhuman primate should we use?
The complexity and refinement in the organization of the cortical and spinal circuitry 
underlying motor behavior have increased gradually during primate evolution from New 
World and Old World monkeys to apes and humans. Accordingly, the nonhuman primate 
to be used will depend on the specific questions being asked. However, on the basis 
of current experience and neurophysiological and neuroanatomical data, the macaque 
monkey provides a clear advantage for the translation of the findings to humans. Owing to 
its relatively large size, the macaque monkey is more comparable to humans with respect 
to metabolism, pharmacodynamics, time frame of treatment and blood-brain barrier 
properties. Moreover, the macaque monkey, as opposed to marmosets, squirrels and spider 
monkeys, has the advantage of being easily trained to use the hand, presumably because 
the projection patterns of its CST (including direct connections with motoneurons) and its 
nonprimary motor cortical areas are most similar to those of humans. Macaque monkeys 
also possess the cognitive ability to learn and to perform tasks used by humans. Indeed, 
they have historically been the monkeys of choice for all studies involving single-unit 
recordings during fine motor control movements, as well as for research on brain-machine 
interfaces. Consequently, macaque monkeys are better suited than prosimian primates and 
New World monkeys to model humans when the potential of neural repair interventions 
that promote recovery of fine motor skills after a SCI or other debilitating condition is 
being investigated8. In fact, there is currently no good scientific rationale for carrying out 
SCI research in apes (bonobo, chimpanzee, gorilla and orangutan).
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mechanisms of recovery that can be attrib-
uted to the regeneration of specific ascending 
or descending tracts or to intraspinal path-
ways. Mechanistic understanding of therapy- 
mediated motor recovery could be critical to 
the selection of a SCI population for a clinical 
trial: that is, individuals with a complete lesion 
would not benefit from intervention-enhanced 
sprouting of spared fibers, whereas such sprout-
ing could promote significant improvements in 
individuals with incomplete injuries.
Incomplete spinal cord transection models 
have some significant advantages over contu-
sion models and retain sufficient relevance to 
the human condition to be a model of choice 
for testing the efficacy of many therapies. 
However, it could become important to test 
the effectiveness of some therapeutic inter-
ventions after incomplete transection injuries 
if fundamental differences in the responses of 
the spinal cord to surgical and contused inju-
ries are identified.
Complete transection. Very significant 
insights into the plastic mechanisms that 
underlie recovery of posture and locomotion 
after SCI have been obtained using the com-
plete spinal cord transection model of mice, 
rats and cats.
So far, experiments suggest that the mecha-
nisms of recovery from complete and incom-
plete SCI may be fundamentally different. 
Whereas true axonal regeneration may be the 
probable mechanism underlying functional 
recovery after a complete injury, local and 
supraspinal plasticity of intact fibers and their 
reorganization may be the main factor after 
an incomplete injury28. So, an anatomically 
complete transection injury could be another 
approach if the proposed therapy has been 
unequivocally shown to induce true axonal 
regeneration in rodents.
Nevertheless, the profound consequences of 
an anatomically complete transection injury on 
the general health of nonhuman primates, the 
associated psychological trauma for the animal, 
and the labor-intensive and skilled daily care 
required to maintain a desirable state of health 
must be carefully balanced with the potential 
benefit for humans. Furthermore, the possibil-
ity of obtaining the information deemed to be 
most critical using rodents or other nonpri-
mate models must be thoroughly examined 
before consideration of using this model in 
nonhuman primates.
Level of lesion. The spinal level of SCI—
cervical, thoracic or sacral—is an important 
decision. Most demographic studies reveal 
that in humans cervical injuries are more fre-
quent than SCI at the thoracic or lower level. 
Experimental lesions at the cervical level make 
it possible to study the recovery of manual dex-
terity. This paradigm affords the most detailed 
assessment of the recovery of fine motor con-
trol and could be a major advantage of using 
nonhuman primates in the translation of a 
therapy to humans. Even limited sprouting or 
regeneration in the cervical spinal cord associ-
ated with recovery of some aspects of the fine 
motor function can be extremely beneficial to 
humans.
On the other hand, injury of the nonhuman 
primate thoracic spinal cord allows the testing 
of recovery of locomotor and postural activi-
ties15. Thoracic injuries present a different type 
of challenge from cervical lesions in that the 
descending and ascending tracts may need to 
form new connections over much longer dis-
tances in order to become functional.
Rehabilitation programs. Rehabilitation 
programs are an integral part of the care of 
patients after SCI. When considered in a pre-
clinical setting, regenerative interventions for 
the injured nonhuman primate spinal cord 
should be combined with a carefully controlled 
rehabilitation program, as any intervention 
in humans will be accompanied by extensive 
rehabilitation. This scenario may be particu-
larly important for regaining and maintaining 
precise motor control of the hands and digits.
Critical variables related to activity will 
need to be collected to define the interaction 
between use-dependent factors and the neural 
plasticity that can occur owing to a regenera-
tive intervention29. Indeed, rehabilitation could 
drive plasticity in a useful direction, while 
concomitant intervention-mediated effects 
could be manifested poorly without training. 
Theoretically, training improves the function 
of existing circuits that can mediate coordi-
nated movements. Nevertheless, we need to 
determine the optimal dosage and time point 
to start the regenerative intervention and reha-
bilitation in primates.
There is much to be gained from the study 
of both fine motor control and locomotion in 
combination with neural regenerative and use-
dependent factors, in terms of translating SCI 
studies from nonhuman primates to humans. 
As recovery of function is a product of neuro-
logical and use-dependent factors, nonhuman 
primates are a superior human surrogate for 
the examination of the interactions of cogni-
tive and motivational factors associated with 
physical therapy and other neurobiological 
interventions.
Conclusion
Nonhuman primates provide unique advan-
tages over rodents for testing and under-
standing the safety and efficacy of reparative 
interventions to promote functional recovery 
after SCI in humans. Nonhuman primates 
provide an opportunity to examine simulta-
neously and comprehensively the effects of a 
regeneration-inducing intervention on mul-
tiple variables such as fine motor control of 
the arm and hand, posture and locomotion 
(bipedal and quadrupedal), and autonomic 
function (such as bladder and bowel con-
trol). Capitalizing on these unique advan-
tages is particularly significant in identifying 
new ways to regain control of sensorimotor 
Table 2  Advantages and disadvantages of commonly used spinal cord injury models for translational studies in nonhuman primates
 Contusion Anatomically incomplete transection Anatomically complete transection
Advantages Relevance to most human SCI (blunt trauma)
Reasonably reproducible injury
Particularly suitable for the study of  
neuroprotective therapy
Critical physiological functions are preserved
Less animal handling is needed
Defining mechanisms of recovery 
Permanent, but modest, impairments  
allow the investigation of therapy-mediated  
functional improvements
Axonal regeneration can be demonstrated 
more definitively
Recovery of voluntary movements from  
complete paralysis unequivocally  
demonstrates therapy-mediated effects
Disadvantages 
 
 
 
 
 
Ischemia, cavity formation and tissue sparing
Major loss of function with severe contusion
Significant focus on daily care of the animal
Difficult to distinguish between spared and 
regenerated nerve fibers
May be less relevant than contusion injury for 
human SCI
Sprouting of spared fibers, as opposed to 
regeneration of cut axons, can be the main 
mechanism of recovery 
High impact on the general health of the 
animal
Psychological trauma
Labor-intensive and skilled daily care 
The major functional impairment for the 
animal must be carefully balanced with the 
potential benefits to be gained for humans
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function of distal upper limb segments and 
digits. Furthermore, rehabilitative therapies 
involving skilled manual motor tasks and 
bipedal locomotion could be administered to 
nonhuman primates on a regular basis. Finally, 
the high risk of a hazard and/or malfunction 
that could accompany an invasive therapy in 
human subjects underscores the advantages of 
understanding the safety factors in the nonhu-
man primate before implementing an inter-
vention on humans.
The pathway for developing the most effec-
tive novel interventions to the greatest number 
of SCI patients would probably include experi-
ments using nonhuman primates. However, 
most of the fundamental work on neurological 
diseases, including SCI, can and should con-
tinue to be performed in rodents and other 
animals. Nonhuman primates should be used 
to test invasive neural interventions that are 
successful in nonprimate species and, as a 
consequence, have a more reasonable poten-
tial for success in humans. Such studies can 
pinpoint the specific potential benefits, iden-
tify the mechanisms of recovery of function, 
and raise our confidence in the level of efficacy 
and safety of an intervention before we con-
sider human clinical trials. Given the common 
elements underlying a range of neuromotor 
disorders, the potential for capitalizing on the 
translational studies in nonhuman primates 
designed to augment motor recovery following 
SCI extends well beyond this specific injury.
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